trending Market Intelligence /marketintelligence/en/news-insights/trending/DR4oyLkJE1w4BeZqzIG0FQ2 content esgSubNav
In This List

Biotechnology company Inscripta raises $125M in series D round

Blog

Insight Weekly: US election scenarios; borrowing costs rise; commercial REIT fears

Podcast

Street Talk | Episode 100 - KBW CEO offers optimism for bears fearful of bank liquidity, credit

Blog

Insight Weekly: Stocks endure more pain; bank branch M&A slows; debt ratios fall

Blog

Insight Weekly: Unease roils markets; US likely to slip into recession; firms' cash ratios fall


Biotechnology company Inscripta raises $125M in series D round

Inscripta Inc. raised $125 million in its series D funding round, which was led by Paladin Capital Group.

New investors JS Capital Management LLC and Oak HC/FT Partners LLC participated in the round, alongside existing investors.

Inscripta has now raised a total of $259.5 million.

Inscripta is a Boulder, Colo.-based biotechnology company that is developing a benchtop platform for genome-scale engineering.